Şevin Turcan

10.5k total citations · 2 hit papers
40 papers, 4.4k citations indexed

About

Şevin Turcan is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Şevin Turcan has authored 40 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 20 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Şevin Turcan's work include Glioma Diagnosis and Treatment (20 papers), Epigenetics and DNA Methylation (15 papers) and Histone Deacetylase Inhibitors Research (7 papers). Şevin Turcan is often cited by papers focused on Glioma Diagnosis and Treatment (20 papers), Epigenetics and DNA Methylation (15 papers) and Histone Deacetylase Inhibitors Research (7 papers). Şevin Turcan collaborates with scholars based in United States, Germany and China. Şevin Turcan's co-authors include Timothy A. Chan, Craig B. Thompson, Patrick S. Ward, Chao Lü, Ross L. Levine, Ingo K. Mellinghoff, Agnès Viale, Armida W. M. Fabius, Jason T. Huse and Luc G.T. Morris and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Şevin Turcan

38 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH mutation impairs histone demethylation and results in a block to cell differentiation

2012 1.5k citations Chao Lü, Patrick S. Ward et al. Nature profile →
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

2012 1.4k citations Şevin Turcan, Daniel Rohle et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Şevin Turcan United States	18	3.0k	1.8k	1.8k	526	436	40	4.4k
Olga A. Guryanova United States	17	2.0k 0.7×	1.1k 0.6×	1.1k 0.7×	645 1.2×	258 0.6×	36	3.0k
Fonnet E. Bleeker Netherlands	19	1.4k 0.5×	1.1k 0.6×	1.3k 0.8×	453 0.9×	435 1.0×	43	2.7k
Marc Remke Germany	37	3.7k 1.2×	1.3k 0.7×	2.8k 1.6×	719 1.4×	500 1.1×	120	5.4k
Esther Hulleman Netherlands	28	2.3k 0.8×	875 0.5×	1.1k 0.6×	1.1k 2.0×	307 0.7×	81	3.7k
Genglin Jin United States	15	3.0k 1.0×	2.4k 1.3×	3.3k 1.9×	666 1.3×	864 2.0×	22	5.8k
Joon H. Uhm United States	37	1.7k 0.6×	1.1k 0.6×	2.1k 1.2×	907 1.7×	764 1.8×	127	4.4k
Kyeung Min Joo South Korea	37	2.9k 1.0×	1.4k 0.7×	1.3k 0.8×	1.6k 3.0×	564 1.3×	135	5.3k
Mario L. Suvà United States	21	3.2k 1.1×	1.4k 0.8×	946 0.5×	947 1.8×	392 0.9×	47	4.4k
Logan A. Walsh Canada	26	1.7k 0.6×	1.1k 0.6×	868 0.5×	979 1.9×	429 1.0×	55	3.4k

Countries citing papers authored by Şevin Turcan

Since Specialization

Citations

This map shows the geographic impact of Şevin Turcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şevin Turcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şevin Turcan more than expected).

Fields of papers citing papers by Şevin Turcan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şevin Turcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şevin Turcan. The network helps show where Şevin Turcan may publish in the future.

Co-authorship network of co-authors of Şevin Turcan

This figure shows the co-authorship network connecting the top 25 collaborators of Şevin Turcan. A scholar is included among the top collaborators of Şevin Turcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şevin Turcan. Şevin Turcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chao, Grace F., Uduak Z. George, Ingrid R. Niesman, et al.. (2025). Catalytically distinct metabolic enzyme isocitrate dehydrogenase 1 mutants tune phenotype severity in tumor models. Journal of Biological Chemistry. 301(5). 108477–108477.

Cui, Haijun, Christel Herold‐Mende, Markus Reischl, et al.. (2023). Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip. Advanced Healthcare Materials. 12(24). e2300591–e2300591. 9 indexed citations

Narayanan, Ashwin, Inmaculada Hernández, Juan C. Nieto, et al.. (2023). Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas. Cell Reports Medicine. 4(11). 101249–101249. 18 indexed citations

Fresnais, Margaux, Aubry K. Miller, Şevin Turcan, et al.. (2023). Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA. Cancers. 15(3). 716–716. 1 indexed citations

Narayanan, Ashwin, Damir Krunic, Marion Bähr, et al.. (2022). MEOX2 homeobox gene promotes growth of malignant gliomas. Neuro-Oncology. 24(11). 1911–1924. 17 indexed citations

Al‐Ali, Ruslan, Ashwin Narayanan, Manuela Brom, et al.. (2022). TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. Neuro-Oncology. 25(6). 1031–1043. 16 indexed citations

Fresnais, Margaux, Şevin Turcan, Dirk Theile, et al.. (2021). Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma. Biomedicines. 10(1). 1–1. 10 indexed citations

Park, Jong‐Whi, Felix Sahm, Isabel Arrillaga‐Romany, et al.. (2020). TERT and DNMT1 expression predict sensitivity to decitabine in gliomas. Neuro-Oncology. 23(1). 76–87. 27 indexed citations

Narayanan, Ashwin, et al.. (2020). Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq. Journal of Visualized Experiments. 11 indexed citations

10.

Al‐Ali, Ruslan, Katharina Bauer, Jong‐Whi Park, et al.. (2019). Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas. Acta Neuropathologica Communications. 7(1). 201–201. 16 indexed citations

11.

Walsh, Logan A., David M. Roy, Marsha Reyngold, et al.. (2014). RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch. Oncogene. 34(17). 2189–2203. 32 indexed citations

12.

Gerber, Naamit K., Anuj Goenka, Şevin Turcan, et al.. (2014). Transcriptional diversity of long-term glioblastoma survivors. Neuro-Oncology. 16(9). 1186–1195. 67 indexed citations

13.

Reyngold, Marsha, Şevin Turcan, Dilip D. Giri, et al.. (2014). Remodeling of the Methylation Landscape in Breast Cancer Metastasis. PLoS ONE. 9(8). e103896–e103896. 26 indexed citations

14.

Turcan, Şevin, Armida W. M. Fabius, Alexandra Borodovsky, et al.. (2013). Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine. Oncotarget. 4(10). 1729–1736. 191 indexed citations

15.

Graham, Christine, et al.. (2012). The cochlea as an independent neuroendocrine organ: Expression and possible roles of a local hypothalamic–pituitary–adrenal axis-equivalent signaling system. Hearing Research. 288(1-2). 3–18. 13 indexed citations

16.

Turcan, Şevin, Daniel Rohle, Anuj Goenka, et al.. (2012). IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 483(7390). 479–483. 1382 indexed citations breakdown →

17.

Graham, Christine, et al.. (2011). The Cochlear CRF Signaling Systems and their Mechanisms of Action in Modulating Cochlear Sensitivity and Protection Against Trauma. Molecular Neurobiology. 44(3). 383–406. 16 indexed citations

18.

Turcan, Şevin, Donna K. Slonim, & Douglas E. Vetter. (2010). Lack of nAChR Activity Depresses Cochlear Maturation and Up-Regulates GABA System Components: Temporal Profiling of Gene Expression in α9 Null Mice. PLoS ONE. 5(2). e9058–e9058. 17 indexed citations

19.

Turcan, Şevin, et al.. (2010). Corticotropin‐releasing factor‐2 activation prevents gentamicin‐induced oxidative stress in cells derived from the inner ear. Journal of Neuroscience Research. 88(13). 2976–2990. 13 indexed citations

20.

Turcan, Şevin, et al.. (2010). MINING FUNCTIONALLY RELEVANT GENE SETS FOR ANALYZING PHYSIOLOGICALLY NOVEL CLINICAL EXPRESSION DATA. WORLD SCIENTIFIC eBooks. 50–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact